Fatty acid synthase (Fasn) is the key metabolic enzyme that accounts for the terminal
catalytic step in fatty acid synthesis, which is hyperactivated in various tumors. In this study …

Objective In the present study, we aimed to investigate the potential role of fatty acid
synthase (FASN) in the development and progression of colorectal cancer (CRC). Materials …

Aim: Fatty acid synthase (FASN), a key enzyme for de novo synthesis of fatty acids, has been
identified as an oncogene in some tumor types; however, the function of FASN in gastric …

Fatty acid synthase (FASN), a lipogenic enzyme, is upregulated in colorectal cancer (CRC).
Increased de novo lipid synthesis is thought to be a metabolic adaptation of cancer cells that …

Fatty acid synthase (FASN), responsible for the de novo synthesis of fatty acids, has been
shown to act as an oncogene in various human cancers. However, the mechanisms by …

Purpose Altered cellular metabolism has received increased attention as an important
hallmark of cancer. Activation of FASN has been found to be involved in many human …

Altered lipid metabolism is a potential target for therapeutic intervention in cancer.
Overexpression of Fatty Acid Synthase (FASN) correlates with poor prognosis in colorectal …

Cell metabolism abnormalities are closely related to tumor occurrence and development.
Fatty acid synthase (FASN) is the key molecule for catalyzing fatty acid synthesis. Increasing …

Fatty acid synthase (FASN) has been shown to be selectively up‐regulated in cancer cells to
drive the development of cancer. However, the role and associated mechanism of FASN in …

Upregulation of fatty acid synthase (FASN), a key enzyme of de novo lipogenesis, is
associated with metastasis in colorectal cancer (CRC). However, the mechanisms of …